- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01342107
Effect of FID 114675A on Lens Wettability
March 21, 2012 updated by: Alcon Research
The Effect of Alcon Multi-Purpose Disinfecting Solution (MPDS) on Lens Wettability
The purpose of this study is to evaluate lens wettability of contact lenses when used with an investigational multi-purpose disinfecting solution.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76314
- Contact Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 years or age or older with normal eyes, other than correction for refractive error.
- At least 5 days successful daily wear (minimum 8 hours per day) of PureVision®, Acuvue® Oasys™, or Acuvue® 2 contact lenses prior to Visit 1
- Vision correctable to 20/30 (Snellen) or better in each eye at distance with lenses at Visit 1 (Day 0 - Baseline).
- Grade 0 or Grade 1 wettability in both eyes after at least 15 minutes of lens wear at Visit 1 (Day 0 - Baseline).
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any ocular or systemic medical condition that may, in the opinion of the investigator, preclude safe administration of the test articles or affect the results of the study.
- Need to wear contact lenses on an extended wear basis (i.e., overnight) during the study.
- Use of products other than a multi-purpose solution or hydrogen peroxide solution, including daily and enzyme cleaners and saline rinses, for lens care at least 7 days prior to Visit 1 (Day 0 - Baseline).
- Use of over-the-counter (OTC) or prescribed topical ocular medications within 7 days prior to Visit 1. Use of lens rewetting drops is acceptable.
- History or current ocular infections or ocular inflammatory events.
- Ocular surgery within the past year.
- Participation in any investigational study within the past 30 days.
- Other protocol-defined exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: FID 114675A
Contact lens soaked overnight in an investigational multi-purpose disinfecting solution randomly assigned to one eye, with contact lens removed directly from the blister pack assigned to the fellow eye for contralateral wear.
Both products worn for one day, 16 hours.
|
Investigational multi-purpose disinfecting solution intended for use as a cleaning, reconditioning, rinsing, disinfecting, and storage solution for silicone hydrogel and soft contact lenses.
Soft hydrogel or silicone hydrogel contact lens matching subject's pre-study lens, including parameters, worn 16 hours on day of dispense.
Other Names:
|
|
ACTIVE_COMPARATOR: Blister Pack
Contact lens removed directly from the blister pack randomly assigned to one eye, with contact lens soaked overnight in an investigational multi-purpose disinfecting solution assigned to the fellow eye for contralateral wear.
Both products worn for one day, 16 hours.
|
Soft hydrogel or silicone hydrogel contact lens matching subject's pre-study lens, including parameters, worn 16 hours on day of dispense.
Other Names:
Commercially approved storage solution as found in the contact lens blister pack.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Wettability
Time Frame: 16 hours
|
As assessed by the investigator during slit-lamp exam and rated on a 0-4 scale, with 0 = a smooth uniformly reflecting wettable surface; 1 = a coarse hazy wettable surface which seems resolved momentarily with each blink and becomes exacerbated with staring; 2 = one stable dry (non-wetting) area of some magnitude; 3 = more than one stable dry (non-wetting) area of some magnitude; 4 = non-wettable lens surface of severe magnitude.
Lenses with a Grade 0 or 1 were rated as wettable and reported as a percentage of total lenses evaluated.
|
16 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (ACTUAL)
February 1, 2011
Study Completion (ACTUAL)
February 1, 2011
Study Registration Dates
First Submitted
January 7, 2011
First Submitted That Met QC Criteria
April 25, 2011
First Posted (ESTIMATE)
April 27, 2011
Study Record Updates
Last Update Posted (ESTIMATE)
April 13, 2012
Last Update Submitted That Met QC Criteria
March 21, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- C-10-024
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contact Lens Wettability
-
EV Clinical TrialsCompletedContact Lens Discomfort | Contact Lens | Contact Lens DrynessUnited States
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
Aston UniversityCooperVision, Inc.Enrolling by invitationContact Lens Wear | Healthy Participants Study | Contact Lens FitUnited Kingdom
-
Ohio State UniversityCompletedContact LensUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
Ohio State UniversityAlcon ResearchCompleted
-
Glia, LLCCompletedContact Lens Discomfort | Contact Lens-induced Corneal Disorder | Contact Lens Acute Red Eye | Contact Lens-induced Corneal Fluorescein StainingUnited States
-
Ohio State UniversityAlcon ResearchCompleted
-
University Hospital, CaenNot yet recruitingContact Lens ComplicationFrance
Clinical Trials on FID 114675A multi-purpose disinfecting solution (MPDS)
-
Alcon ResearchCompletedSymptomatic Contact Lens WearersUnited States
-
Alcon ResearchCompletedMyopia | Contact Lens Fit
-
Alcon ResearchCompletedContact Lens MoistureUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedHealthy Contact Lens WearersUnited States
-
Alcon ResearchCompletedEvaluation of an Investigational Multi-Purpose Disinfecting Solution for Care of Soft Contact LensesContact Lens CareUnited States
-
Alcon ResearchCompletedContact Lens CareUnited States
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedContact Lens CareUnited States
-
Alcon ResearchCompletedRefractive Error | Astigmatism | Myopia | Hyperopia